Ovarian Germ Cell Tumor

Ovarian Germ Cell Tumors arise from egg-producing cells of the ovary.

Most are benign, but malignant variants need surgical and chemotherapeutic care tailored for young women.

Overview And Clinical Background

These tumors are rare and often occur in adolescents or young adults.

Prognosis is excellent with prompt diagnosis and treatment.

Key point:Represents less than 5% of ovarian cancers.

Most cases are curable even in advanced stages.

Third point:Fertility preservation is possible in many cases.

Patients may notice abdominal swelling or pain.

Hormonal changes may lead to menstrual irregularities.

Common symptom:Abdominal mass or discomfort.

Rapid increase in abdominal size.

Red flag:Acute pain from torsion or rupture.

Diagnosis involves imaging and tumor marker testing.

Histological classification determines treatment.

Imaging:Ultrasound or MRI identifies tumor origin and size.

Lab tests:AFP, hCG, and LDH help in diagnosis and follow-up.

Tissue biopsy confirms the tumor subtype.

Surgery is the primary treatment, followed by chemotherapy in malignant cases.

Organ preservation is prioritized in young women.

Conservative:Unilateral oophorectomy for localized benign lesions.

Minimally invasive options:Laparoscopic cystectomy for early tumors.

Debulking surgery for advanced or recurrent cases.

Excellent prognosis with appropriate therapy.

Fertility often remains intact after conservative treatment.

CureU Healthcare offers fertility-sparing, advanced oncology treatments designed for young women with germ cell tumors.

Early intervention ensures high survival and preserved quality of life for ovarian germ cell tumor patients.